Forensic Analysis · Oura IPO · September 2026 THE IPO DID NOT HAPPEN. OURA’S REAL TROUBLE STARTS NOW. The offering was postponed at the last minute. That is not the end of the story. It is the moment when Oura’s financial engineering, marketing claims, regulatory exposure and public-company readiness became impossible to examine separately. By […]
The IPO Did Not Happen. OURA’S Real Trouble Starts Now Read More »
The Quantified Human Who Forgot How to Feel We are measuring ourselves more than at any time in human history. We know ourselves less. Every morning, millions of people wake up and, before asking how they feel, look at a screen. How did I sleep? The answer apparently no longer comes from the person who
THE QUANTIFIED HUMAN WHO FORGOT HOW TO FEEL Read More »
Forensic Analysis · Oura S-1 · Part III OURA’S HEALTH-CLAIMS GAP: WHAT THE MARKETING PROMISES—AND THE S-1 LEGALLY CONCEDES Marketing sells a health system. The legal filing describes a wellness product—with narrow exceptions, no U.S. device marketing authorizations, unverified testimonials, accuracy risks, and an AI coach that can invent answers. By Dr. Bomi Joseph, MD,
Part III: OURA vs. OURA — The Health-Claims Gap Read More »
Forensic Analysis · Oura S-1 · Part II OURA’S 85% RETENTION QUESTION: WHO ACTUALLY PAID—AND WHO ACTUALLY STAYED? Oura markets five million members, 94% conversion and 85% retention. Its September 3 S-1 reveals that “Paid Members” can include failed payments and free concessions, partner programs can pay for the user, and cancelled members who return
Part II: Oura’s 85% Retention Question—Who Actually Paid, and Who Actually Stayed? Read More »
Follow the Money: Examining the financial disclosures behind Oura’s membership business and pre-IPO share repurchases.
Discover the science behind Deep Health®—a system that reveals your real, internal wellness. Learn why surface health isn’t enough.
What Is Deep Health® and Why It Matters | Dr. Bomi Joseph Read More »
